These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 36910075)

  • 41. Thromboembolic Risk in Nonanticoagulated Patients With Atrial Fibrillation and Valvular Heart Disease.
    Melgaard L; Overvad TF; Jensen M; Lip GYH; Larsen TB; Nielsen PB
    JACC Clin Electrophysiol; 2020 Dec; 6(13):1672-1682. PubMed ID: 33334446
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Negative impact of atrial fibrillation and pulmonary hypertension after mitral valve surgery in asymptomatic patients with severe mitral regurgitation: a 20-year follow-up.
    Coutinho GF; Garcia AL; Correia PM; Branco C; Antunes MJ
    Eur J Cardiothorac Surg; 2015 Oct; 48(4):548-55; discussion 555-6. PubMed ID: 25564214
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Valvular Heart Disease in Adults: Management of Native Valve Disease.
    Zhang X; Hollenberg SM
    FP Essent; 2017 Jun; 457():17-22. PubMed ID: 28671805
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study.
    d'Arcy JL; Coffey S; Loudon MA; Kennedy A; Pearson-Stuttard J; Birks J; Frangou E; Farmer AJ; Mant D; Wilson J; Myerson SG; Prendergast BD
    Eur Heart J; 2016 Dec; 37(47):3515-3522. PubMed ID: 27354049
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Frequency and predictors of atrial fibrillation in severe mitral regurgitation].
    Duran NE; Duran I; Sönmez K; Gençbay M; Akçay A; Turan F
    Anadolu Kardiyol Derg; 2003 Jun; 3(2):129-34. PubMed ID: 12826507
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Left-sided valvular heart disease and survival in out-of-hospital cardiac arrest: a nationwide registry-based study.
    Dejby E; Bhatt DL; Skoglund K; Rawshani A; Omerovic E; Redfors B; Myredal A; Petursson P; Angerås O; Gustafsson A; Isaksén D; Herlitz J; Rawshani A
    Sci Rep; 2023 Aug; 13(1):12662. PubMed ID: 37542095
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease.
    Iung B; Baron G; Butchart EG; Delahaye F; Gohlke-Bärwolf C; Levang OW; Tornos P; Vanoverschelde JL; Vermeer F; Boersma E; Ravaud P; Vahanian A
    Eur Heart J; 2003 Jul; 24(13):1231-43. PubMed ID: 12831818
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiac valvular surgery and history of anorectic drug intake: A retrospective study of a large population of benfluorex-exposed patients.
    Laurent M; Ennezat PV; Malergue MC; Bruneval P;
    Arch Cardiovasc Dis; 2022; 115(6-7):348-358. PubMed ID: 35697655
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetically Predicted Atrial Fibrillation and Valvular Heart Disease: A Two-Sample Mendelian Randomization Study.
    Gao J; Bai Y; Ji H
    Front Cardiovasc Med; 2022; 9():845734. PubMed ID: 35419428
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Calreticulin overexpression correlates with integrin-α5 and transforming growth factor-β1 expression in the atria of patients with rheumatic valvular disease and atrial fibrillation.
    Zhao F; Zhang S; Shao Y; Wu Y; Qin J; Chen Y; Chen L; Gu H; Wang X; Huang C; Zhang W
    Int J Cardiol; 2013 Oct; 168(3):2177-85. PubMed ID: 23465222
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease.
    Renda G; Ricci F; Giugliano RP; De Caterina R
    J Am Coll Cardiol; 2017 Mar; 69(11):1363-1371. PubMed ID: 28302287
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predictive value of left atrial appendage lobes on left atrial thrombus or spontaneous echo contrast in patients with non-valvular atrial fibrillation.
    Wang F; Zhu M; Wang X; Zhang W; Su Y; Lu Y; Pan X; Gao D; Zhang X; Chen W; Xu Y; Sun Y; Xu D
    BMC Cardiovasc Disord; 2018 Jul; 18(1):153. PubMed ID: 30064363
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence and correlates of valvular heart diseases in the elderly population in Hubei, China.
    Shu C; Chen S; Qin T; Fu Z; Sun T; Xie M; Zhang L; Dong N; Yin P
    Sci Rep; 2016 Jun; 6():27253. PubMed ID: 27250873
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gene expression profile associated with chronic atrial fibrillation and underlying valvular heart disease in man.
    Lamirault G; Gaborit N; Le Meur N; Chevalier C; Lande G; Demolombe S; Escande D; Nattel S; Léger JJ; Steenman M
    J Mol Cell Cardiol; 2006 Jan; 40(1):173-84. PubMed ID: 16242148
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation.
    Gaborit N; Steenman M; Lamirault G; Le Meur N; Le Bouter S; Lande G; Léger J; Charpentier F; Christ T; Dobrev D; Escande D; Nattel S; Demolombe S
    Circulation; 2005 Jul; 112(4):471-81. PubMed ID: 16027256
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Value of D-dimer and left atrial size combined with CHA
    Wu CC; Li XB; Duan JB; He JS; Zhu TG; Yu C; Li D; Ze F; Guo JH; Wang L
    Zhonghua Yi Xue Za Zhi; 2021 Dec; 101(48):3938-3943. PubMed ID: 34954995
    [No Abstract]   [Full Text] [Related]  

  • 57. Point-of-Care Ultrasound in Detection, Severity and Mechanism of Significant Valvular Heart Disease and Clinical Management.
    Wen S; Naqvi TZ
    J Clin Med; 2023 Oct; 12(20):. PubMed ID: 37892613
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antithrombotic therapy in elderly patients with non-valvular atrial fibrillation: a pilot study.
    Xiang W; Zhang J; Liu M; Liu F; Feng X; Wang Y
    Clin Interv Aging; 2015; 10():515-9. PubMed ID: 25767378
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Valvular Heart Disease Epidemics.
    Domenech B; Pomar JL; Prat-González S; Vidal B; López-Soto A; Castella M; Sitges M
    J Heart Valve Dis; 2016 Jan; 25(1):1-7. PubMed ID: 29505225
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of potential roles of combinatorial microRNA regulation in occurrence of valvular heart disease with atrial fibrillation based on computational evidences.
    Wang G; Rao N; Liu D; Jiang H; Liu K; Yang F; Chen Y; Huang K
    PLoS One; 2019; 14(9):e0221900. PubMed ID: 31479479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.